drugset / Trial / NCT01193270
Vitamin E for Extremely Preterm Infants
Phase 1
Completed
93 enrolled
NICHD Neonatal Research Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collabNational Center for Research Resources (NCRR) · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this pilot trial is to test the safety and efficacy of administering one dose of vitamin E, via a tube into the stomach, to extremely preterm infants (less than 27 weeks gestation and less than 1000 grams birth weight). This pilot will examine whether a single dose of vitamin E will be absorbed into the infants' bloodstreams with resulting serum α-tocopherol level in the target range of 1-3 mg/dl.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin E | Other / unclassified | 50 iu/kg | Other |